Guidance to market authorization holders on issuing health product risk communications: Overview

Guidance to market authorization holders on issuing health product risk communications: Overview The purpose of this document is to assist market authorization holders (MAHs) develop and disseminate health product risk communications (HPRCs). 2024-03-30 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyGuidancemarket authorization holdershealth-product risk communicationsoverview Guidance to market authorization holders on issuing health product risk communications: OverviewHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/reports-publications/medeffect-canada/guidance-market-authorization-holders-on-issuing-health-product-risk-communications.html Guidance to market authorization holders on issuing health product risk communications: OverviewHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/rapports-publications/medeffet-canada/lignes-directrices-intention-detenteurs-autorisation-mise-en-marche-concernant-diffusion-communications-risques-lies-produits-sante.html

The purpose of this document is to assist market authorization holders (MAHs) develop and disseminate health product risk communications (HPRCs).

Data and Resources

Similar records